Phenome-wide profiling identifies genotype-phenotype associations in Phelan-McDermid syndrome using family-sourced data from an international registry.

Autor: Yin R; Department of Biomedical Informatics, Harvard Medical School, Boston, MA, 02115, USA.; Department of Health Outcomes and Biomedical Informatics, University of Florida, Gainesville, FL, USA., Wack M; Department of Biomedical Informatics, Harvard Medical School, Boston, MA, 02115, USA., Hassen-Khodja C; Department of Biomedical Informatics, Harvard Medical School, Boston, MA, 02115, USA., McDuffie MT; Department of Biomedical Informatics, Harvard Medical School, Boston, MA, 02115, USA., Bliss G; Phelan-McDermid Syndrome Foundation, Osprey, FL, 34229, USA., Horn EJ; Phelan-McDermid Syndrome Foundation, Osprey, FL, 34229, USA., Kothari C; Department of Biomedical Informatics, Harvard Medical School, Boston, MA, 02115, USA., McLarney B; Phelan-McDermid Syndrome Foundation, Osprey, FL, 34229, USA., Davis R; Phelan-McDermid Syndrome Foundation, Osprey, FL, 34229, USA., Hanson K; Phelan-McDermid Syndrome Foundation, Osprey, FL, 34229, USA., O'Boyle M; Phelan-McDermid Syndrome Foundation, Osprey, FL, 34229, USA., Betancur C; INSERM, CNRS, Neuroscience Paris Seine, Institut de Biologie Paris Seine, Sorbonne Université, 75005, Paris, France. catalina.betancur@inserm.fr., Avillach P; Department of Biomedical Informatics, Harvard Medical School, Boston, MA, 02115, USA. Paul_Avillach@hms.harvard.edu.
Jazyk: angličtina
Zdroj: Molecular autism [Mol Autism] 2024 Sep 30; Vol. 15 (1), pp. 40. Date of Electronic Publication: 2024 Sep 30.
DOI: 10.1186/s13229-024-00619-z
Abstrakt: Background: Phelan-McDermid syndrome (PMS) is a rare neurodevelopmental disorder caused by 22q13 deletions that include the SHANK3 gene or pathogenic sequence variants in SHANK3. It is characterized by global developmental delay, intellectual disability, speech impairment, autism spectrum disorder, and hypotonia; other variable features include epilepsy, brain and renal malformations, and mild dysmorphic features. Here, we conducted genotype-phenotype correlation analyses using the PMS International Registry, a family-driven registry that compiles clinical data in the form of family-reported outcomes and family-sourced genetic test results.
Methods: Data from the registry were harmonized and integrated into the i2b2/tranSMART clinical and genomics data warehouse. We gathered information from 401 individuals with 22q13 deletions including SHANK3 (n = 350, ranging in size from 10 kb to 9.1 Mb) or pathogenic or likely pathogenic SHANK3 sequence variants (n = 51), and used regression models with deletion size as a potential predictor of clinical outcomes for 328 phenotypes.
Results: Our results showed that increased deletion size was significantly associated with delay in gross and fine motor acquisitions, a spectrum of conditions related to poor muscle tone, renal malformations, mild dysmorphic features (e.g., large fleshy hands, sacral dimple, dysplastic toenails, supernumerary teeth), lymphedema, congenital heart defects, and more frequent neuroimaging abnormalities and infections. These findings indicate that genes upstream of SHANK3 also contribute to some of the manifestations of PMS in individuals with larger deletions. We also showed that self-help skills, verbal ability and a range of psychiatric diagnoses (e.g., autism, ADHD, anxiety disorder) were more common among individuals with smaller deletions and SHANK3 variants.
Limitations: Some participants were tested with targeted 22q microarrays rather than genome-wide arrays, and karyotypes were unavailable in many cases, thus precluding the analysis of the effect of other copy number variants or chromosomal rearrangements on the phenotype.
Conclusions: This is the largest reported case series of individuals with PMS. Overall, we demonstrate the feasibility of using data from a family-sourced registry to conduct genotype-phenotype analyses in rare genetic disorders. We replicate and strengthen previous findings, and reveal novel associations between larger 22q13 deletions and congenital heart defects, neuroimaging abnormalities and recurrent infections.
(© 2024. The Author(s).)
Databáze: MEDLINE
Nepřihlášeným uživatelům se plný text nezobrazuje